Sarepta Therapeutics | SRPT - Текущие обязательства

Биржевая цена
21.79
Изменение за день
1.31 6.40%
Ежемесячно
33.52%
Ежегодный
-64.80%
Q1 прогноз
19.37




Текущие обязательства Изменить Дата
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amgen USD 25.49B 3.7B 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
Biogen USD 3.35B 59.4M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Capricor Therapeutics USD 35.84M 7.69M 2025-12
Daiichi Sankyo JPY 778.55B 77.51B 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Insmed USD 468.87M 51.66M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Moderna USD 1.99B 306M 2025-12
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novavax USD 459.95M 30.08M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
PTC Therapeutics USD 968.43M 102.18M 2025-12
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 28.35B 3.76B 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Tectonic Therapeutic USD 9.67M 293K 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12